Status:
UNKNOWN
Antibody Responses in Contacts of COVID-19 Patients
Lead Sponsor:
Assiut University
Conditions:
COVID-19
Eligibility:
All Genders
18-80 years
Brief Summary
After several cases of pneumonia with an unfamiliar etiology were observed at the end of 2019, the National Health Commission of China released more details about the epidemic in early 2020. The patho...
Detailed Description
The SARS-CoV-2 belongs to the genus β which has been confirmed to be highly infectious by research. (https://www.who.int/emergencies/ diseases/novel-coronavirus-2019/situation-reports). The four majo...
Eligibility Criteria
Inclusion
- close contacts of confirmed COVID-19 patients, apparently healthy
Exclusion
- symptomatic close contacts, any close contacts with malignant tumor, stroke, cardiac, respiratory, Gastrointestinal, and renal diseases or any organ dysfunction.
Key Trial Info
Start Date :
June 15 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 30 2020
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04444310
Start Date
June 15 2020
End Date
September 30 2020
Last Update
June 23 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
AssiutU
Asyut, Egypt, 71111